Synectics Regulatory News (SNX)

Synectics plc

(the "Company" or the "Group")

Award of Options under Revised Share Plan

Director PDMR shareholding

Synectics plc (AIM: SNX), a leader in the design, integration and control of advanced surveillance technology and networked security systems, announces that on 9 October 2012 it adopted a revised Executive Share Ownership Plan (the "Revised ExSOP") for Group executives, to replace its existing Executive Share Ownership Plan (the "existing ExSOP"), and made awards over 142,250 ordinary shares of 20p (the "Shares") to certain senior managers employed within the Group.

Under the Revised ExSOP, selected employees are entitled to exercise an option to receive a certain number of Synectics shares at any time after a 3 year vesting period, at no cost to themselves. The number of shares that are awarded at the end of the 3 year period is dependent on the achievement of certain performance criteria.

The performance criteria are identical to those that apply under the existing ExSOP. Provided that the total return on Synectics shares has out-performed the AIM All Share Total Return Index (the "Index") by 5% or more in the three years following the award, beneficiaries will be entitled to receive the full number of shares awarded. If Synectics' share performance matches the Index, then 25% of the awarded shares will vest and between these points vesting will be pro-rata. If the total return on Synectics shares underperforms the Index, then no entitlement will vest. The limit on the number of shares over which interests may be awarded also remains unchanged.

Any entitlement under the Revised ExSOP will lapse on cessation of employment prior to the end of the three year vesting period unless this is by reason of redundancy, ill health or death.

It is intended that if the performance criteria are met in full or part, the appropriate number of Shares will be transferred to the employees from unallocated Synectics shares already held within the employee benefit trust established for the existing ExSOP. 

Full details of the Revised ExSOP will be set out in the Company's Annual Report for the year ending 30 November 2012 which is expected to be issued in March 2013.

As a result of the award of options over the Shares referred to above, John Shepherd and Nigel Poultney, directors of the Company, have acquired an interest in 15,000 and 10,000 Synectics shares respectively.

In addition the Company has been notified that the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") has today purchased, in accordance with the ESAP's rules and on behalf of all ESAP participants, 6,547 ordinary shares of 20 pence each in the Company ("Ordinary Shares"), at a price of 272.5 pence each.

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares in the Company at the end of the contribution period (the "Period") (normally 6 months) based upon the contributions made in the preceding period and determined by the lowest share price at either the beginning of the Period or on the purchase day. In this instance the share price used for ESAP purposes was the price on the purchase day.

The Company was also notified that the above number of Ordinary Shares acquired by the Trustee included 189 Ordinary Shares, purchased as part of the reinvestment of the Company's interim dividend.  

As a result of these purchases, John Shepherd and Nigel Poultney, directors of the Company, have each acquired an interest in 289 Synectics shares.

Following the award of options over the Shares referred to above, and the share purchases in relation to the ESAP, the interests of John Shepherd and Nigel Poultney in Synectics shares are as follows:

.

For further information, please contact: